[Ambulatory management of patients after myocardial infarction].
After a myocardial infarction, the physician should evaluate if his patient has a high risk of complications. Main factors for prognosis are left ventricular systolic function, myocardial ischemia, ventricular arrhythmias and coronary anatomy. Treatment of symptoms and complications (angina, heart failure, ventricular arrhythmias) and drugs aimed at improving prognosis (beta-blockers, platelet inhibitors, angiotensin-converting enzyme inhibitors, estrogen) are discussed. Finally the importance of correcting risk factors is stressed with emphasis on the essential role of statins.
Bloch
A
A
Hôpital de la Tour, Département cardiovasculaire médico-chirurgical, Meyrin-Genève.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000553:Ambulatory Care / Q000379:methods*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D001145:Arrhythmias, Cardiac / Q000209:etiology / Q000517:prevention & control; D006333:Heart Failure / Q000209:etiology / Q000517:prevention & control; D006801:Humans; D008019:Life Style; D009203:Myocardial Infarction / Q000150:complications* / Q000188:drug therapy*; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D011379:Prognosis; D012307:Risk Factors
D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D010975:Platelet Aggregation Inhibitors